New AI Offering Creates Industry’s Most Comprehensive Clinical Documentation Suite that Fits Any Workflow

DALLAS: IKS Health, a global leader in care enablement solutions, proudly announces the launch of Scribble Now, the latest addition to the IKS Health Scribble Suite, at ViVE 2025, February 16-19. This real-time documentation solution completes the industry’s most comprehensive AI clinical documentation suite, empowering clinicians to create accurate notes during patient encounters while focusing on delivering exceptional care. IKS Health executives will be showcasing the Scribble Suite in ViVE’s first-ever AI Pavilion at Booth 739.

With Scribble Now, IKS Health combines automated speech recognition (ASR) and Generative AI (GenAI) to enable clinicians to focus on patient care while documenting in real time, reducing after-hours workload and enhancing overall efficiency. Scribble Now’s GenAI prompting is continuously refined with clinician feedback while improving accuracy and addressing common challenges. Combining the power of HIPAA-compliant technology with physician expertise ensures that documentation is precise, contextually accurate, and reliable.

“Scribble Now and our other Suite solutions integrate our custom-built innovative AI capabilities with the feedback and knowledge of clinicians to create and improve flexible workflows while reducing administrative, clinical, and operational burdens,” said Ben Crocker, MD, Senior Vice President of Care Design and Innovation. “This smart solution ensures we deliver accurate documentation in a timely manner, ultimately improving both care delivery and outcomes.”

The IKS Scribble Suite offers five flexible solutions to meet the specific needs of healthcare organizations:

“Offering Scribble Pro [part of the Scribble Suite] has been one of the best decisions we have made to help support our providers, limit burnout, and to impact productivity, all resulting in excellent provider retention and recruitment,” said Patrick McSweeney, MD, President of Milford Regional Physician Group. “Satisfaction with the product and team is quite high, and time saved is a huge win. The AI addition with Pro has made the cost much more manageable for the long term.”

IKS Health recently announced that Scribble Transcribe won the No. 1 spot as the 2025 Best in KLAS provider for the 7th straight year for medical transcription services.

The Scribble Suite exemplifies IKS Health’s commitment to advancing clinician well-being, improving patient outcomes, and ensuring financial sustainability for healthcare organizations.

“The Scribble Suite is one of the many ways our solutions use AI and human-in-the-loop technology to pragmatically address healthcare’s challenges across the patient journey,” said Sri Madabushi, Executive Vice President and General Manager, Value-based Care, at IKS Health. “We’ve created a robust ecosystem that adapts to clinicians’ unique workflows and preferences, ensuring accuracy, efficiency, and better care outcomes, whether you’re in volume or value arrangements.”

For more information about the IKS Health Scribble Suite, visit IKS Health.

About IKS Health

IKS Health takes on the chores of healthcare—spanning administrative, clinical, and operational burdens—so that clinicians can focus on their core purpose: delivering great care. Combining pragmatic technology and dedicated experts, IKS Health enables stronger, financially sustainable enterprises. IKS Health’s Care Enablement Platform delivers data-driven value and expertise across the care journey, and IKS Health is a partner for clinician enterprises looking to effectively scale, improve quality, and achieve cost savings through forward-thinking solutions. Founded in 2006, IKS Health’s global workforce supports large health systems across the United States. For more information on IKS Health and its solutions, please visit ikshealth.com.

Inventurus Knowledge Solutions Limited was listed on National Stock Exchange of India Limited (NSE) and BSE Limited (Bombay Stock Exchange) on December 19, 2024. {Scrip codes: NSE - IKS and BSE - 544309}

Fonte: Business Wire